Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation
Clinical trial NCT02095782 · TERMINATED
Trial details
- NCT number
- NCT02095782
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2017-01-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.